Research Senior Associate
Ohio State University Wexner Medical Center | |
United States, Ohio, Columbus | |
281 West Lane Avenue (Show on map) | |
Feb 03, 2026 | |
|
Position Summary
The Research Senior Associate will assist and support the center for antibody therapeutics (CAT) at the Pelotonia Institute for Immuno-Oncology (PIIO) under direct supervision of Dr. Zhiwei Hu, Managing Director of the PIIO CAT at the OSUCCC James. Research Senior Associate will participate in planning, executing, and analyzing translational cancer research with focus on antibodies/proteins, antibody drug conjugates, bispecific antibodies, antibody-based CAR-NK and CAR-T cell immunotherapy using advanced molecular, cellular and antibody-based techniques. Key Responsibilities
The OSUCCC James is the only cancer program in the United States that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the nations largest public universities. Pelotonia Institute for Immuno-Oncology (PIIO) is a comprehensive bench-to-bedside research initiative focused on harnessing the bodys immune system to fight cancer at all levels - from prevention to treatment and survivorship. The Center for Antibody Therapeutics (CAT) at the PIIO is a specialized technology hub dedicated to the discovery, development, production, optimization, and translation of antibody-based therapeutics from basic science research to preclinical and clinical studies for cancer treatment. The Center will leverage cutting-edge technologies to develop monoclonal antibodies, bispecific antibodies (bsAb), antibody-drug conjugates (ADCs), antibody engineering, and other antibody-based immunotherapies including CAR-T and CAR-NK cells. This center will serve the PIIO research community, clinical teams, and external partners by providing essential expertise and infrastructure to accelerate immuno-oncology research from basic science discovery to translational research, commercialization towards clinical trials in alignment with the overall strategic growth goals of the PIIO. | |
Feb 03, 2026